Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Almirall S.A., Ronda General Mitre, 151, 08022 Barcelona, Spain
Meptid 200 mg Film-Coated Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Oval, biconvex, orange, film-coated tablets. The tablets are engraved “MPL 023” on one side. |
Each tablet contains 200 mg of meptazinol (as hydrochloride).
Excipient with known effect:
Each tablet contains 2.15 mg of sunset yellow FCF (E110).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Meptazinol |
Meptazinol is a centrally acting analgesic belonging to the hexahydroazepine series, which has demonstrated mixed agonist and antagonist activity at opioid receptors. It is used for the short term treatment of moderate pain. |
| List of Excipients |
|---|
|
Tablet Core: Microcrystalline cellulose Tablet Coating: Hypromellose (E464) |
Cartons containing PVC blister packs of 6, 28, 56, 100 or 112 tablets.
Not all pack sizes may be marketed.
Almirall S.A., Ronda General Mitre, 151, 08022 Barcelona, Spain
UK-PL 16973/0017
17 December 1992/11 October 2005
| Drug | Countries | |
|---|---|---|
| MEPTID | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
